Pathology Flashcards

1
Q

What is the greatest cause of lung cancer?

A

smoking

also non smokers

  • asbestos (+smoking 50 fold increase)
  • radiation
  • genetic predisposition
  • heavy metals

p53 gene are housekeeping genes that stop growth of cell to immortal cell line by causing apoptosis - BUT these p53 genes are damaged by smoking

also increasing effect of oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are clinical features of lung cancer?

A

haemoptysis
finger clubbing (angle between nail and nail bed >180)
nicotine staining
cachexia

unexplained/persistent for more than 3 wks

  • cough
  • chest/shoulder pain
  • chest sgins
  • dyspnoea
  • hoarseness

CXR urgent referral
- large mass in R lower lobe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are types of lung cancer, how are they classified for diagnosis?

A

CELL TYPE
non small cell
small cell
SUBTYPE
then further classification (pathology from biopsy)
MOLECULAR PHENOTYPE
- non small cell lung cancer (if PDL-1 over 50% then eligible for immunotherapy)
- adenocarcinoma (look for common mutations for targeted treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How to stage lung cancer?

A

TNM classification
tumour
- size (10mm T1, 30 T2)
- location (if spread - T3)

lymph node (N0-3)
- hilar, mediastinal and contralateral lymph nodes 

metastasis (M0/1)

  • to brain? bone? liver?
  • bone metastases meaning local treatment inefficient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the typical first step for staging of lung cancer? Rest of pathway?

A

CXR

CT THORAX with diagnosis and staging at same time

FDG-PET-CT

  • radio labelled glucose taken up by active heart and brain
  • if taken up by mediastinal lymph nodes indicates metastatic lung cancer

CT biopsy (risk of pneumothorax), endobronchial US

MRI brain - more detail as not clear on PET (high uptake of glucose)

PFTS

patients may also get non metastatic manifestations of lung cancer (wrist pain/ankle pain - e.g. release PTH that causes hypercalcaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the difference in pathway for small and non small cell lung cancers?

A

non small cell - slow growing, try to remove and adjuvant radio/chemotherapy
but if spread to mediastinal lymph nodes give radiotherapy/chemotherapy combination with surgery

small cell - rapidly dividing, treatment based on chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the problem with lung metastasis?

A

tumours spread before we can see them
diagnosis so late that time remaining for survival is minimal

CT screening
stop smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the epidemiology of lung cancer?

A

4th common cause of all mortality in west

death in 80% cases, 5 year survival/cure rate less than 6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diameter of tubular system in lungs?

A

bronchi >1mm
bronchiole <1mm
small airways <2mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main types of lung cancer?

A

BENIGN tumour (can cause obstruction)

MALIGNANT
non small cell - everything else, squamous cell carcinoma (20-40%), adenocarcinoma (20-40%), large cell carcinoma uncommon

early stage 60% 5 yr survival, late stage 5% 5 yr survival, 20-30% tumours early stage and can be resected, less chemosensitive

small cell (20%) - 
undifferentiated, advanced, aggressive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is squamous cell carcinoma?

A
  • cigarette smoke irritates ciliated epithelium in the lung upper airways and this changes cell type by metaplasia as mutations accumulate (lose cilia)
  • invade stroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is adenocarcinoma?

A

MORE COMMON IN NON SMOKERS, spread more early

tumour of glandular epithelium in periphery, terminal airways, interstitium
- atypical cells at start that increase in size and become invasive

  • before invasive = adenocarcinoma in situ (excise early lesions to avoid metastasis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are molecular pathways in adenocarcinoma?

A

smoker
- K ras mutation

non smokers
-EGFR mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is large cell carcinoma?

A
  • poorly differentiated tumours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is small cell carcinoma?

A
- 20-25% tumours
central near bronchi 
- close association with smoking 
- most present with advanced disease
- respond well to chemotherapy/radiotherapy 

survival 2-4 mths intreated, 10-20 treated with chemoradiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is EGFR?

A

membrane receptor tyrosine kinase regulating angiogenesis, proliferation, apoptosis and migration

if mutated - continuous growth

most seen in adenocarcinoma, females, non smokers, asian

target with TKI (Gefitinib)

17
Q

What is ALK?

A

oncogene

upregulated in adenocarcinoma

18
Q

How do tumour cells evade host immune response?

A

express PDL1 that inhibits cytotoxic CD8 T cells

PDL1 inhibitors

19
Q

What is used for cytology?

A
sputum
bronchial washing
pleural fluid
fine needle aspiration 
biopsy (peripheral via transthoracic CT biopsy)
20
Q

What are the local effects of lung cancer?

A

bronchial obstruction
- distal lung collapse (SOB)

  • impaired bronchus drainage (chest infection - pneumonia)
  • invasion of local airways, vessels, SVC obstruction, oesophagus (dysphagia), chest wall (plain)
  • inflammation, invade pleura/pericardium (cardiac compromise, SOB)
21
Q

Physical effect of distant lung cancer spread?

A

brain - fits
skin - lumps
liver
bones

22
Q

What is paraneoplastic syndrome?

A

systemic effect of tumour due to abnormal expression by tumour cells of factors not normally expressed

  • ENDOCRINE e.g. SIADH - hyponatremia, small cell
  • NON ENDOCRINE - haemotological effects